TLCG organizes the "Innovations for Thai Lung Cancer Patients 2020" with the launch "LungAndMe"

Assoc. Prof. Dr. Virote Sriuranpong, M.D. (middle), Chairman of the Thai Lung Cancer Group (TLCG) has organized the "Innovations for Thai Lung Cancer Patients 2020" event to raise awareness and provide the public with a better understanding of lung cancer, in terms of disease severity, risk factors, medical advancements that play a significant role in unveiling the heterogeneity of lung cancer, as well as new treatment options. During the event, 'LungAndMe,' a digital assistant was introduced as a quick access to medical advice from specialized doctors for the lung patients and caregivers. The panel of keynote speakers, including Piyada Sitthideatphaiboon, M.D. (left), Kunlatida Maneenil, M.D. (2nd from left), Assoc. Prof. Thanyanan Reungwetwattana, M.D. (right) and Asst. Prof. Lt. Col. Naiyarat Prasongsook, M.D. (2nd from right) took place recently at Ballroom 3, Shangri-La Hotel.

Nearly 80% of Doctors Worldwide Mistakenly Believe Nicotine Causes Lung Cancer, Thwarting Efforts to Help One Billion Smokers Quit

Survey of more than 15,000 physicians in 11 countries uncovers need for further educationThe Foundation for a Smoke-Free World invites researchers to propose new analysis & educational programs On average, nearly 77% of doctors mistakenly believe nicotine causes lung cancer and 78% believe it causes atherosclerosis. While on average 87% of doctors at least moderately agree that helping patients quit smoking is a priority, lack of training and nicotine knowledge adversely impacts quitting and

20 กรกฎาคม 2566 09:00 น.

แอสตร้าเซนเนก้า ประเทศไทย ประกาศความร่วมมือ โรงพยาบาลพญาไท 2 นำนวัตกรรม AI เพิ่มประสิทธิภาพการตรวจหามะเร็งปอดระยะเริ่มต้น — บริษัท แอสตร้าเซนเนก้า (ประเทศ... มี.ค. 66

เสวนาวันมะเร็งปอดโลก: ดูแลปอด ดูแลใจ เพื่อผู้ป่วยมะเร็งปอด — วันมะเร็งปอดโลกซึ่งตรงกับวันที่ตรงกับวันที่ 1 สิงหาคมของทุกปี จัดขึ้นเพื่อรณรงค์ให้คนทั่วโลกห... ส.ค. 64

TLCG organizes the "Innovations for Thai Lung Cancer Patients 2020" with the launch "LungAndMe" — Thai Lung Cancer Group (TLCG) organizes the "Innovations... ธ.ค. 63

Innovations for Thai Lung Cancer Patients 2020 launch "LungAndMe" — Innovations for Thai Lung Cancer Patients 2020: evolving treatments for lung cancerBri... ธ.ค. 63

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Not intended for UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial... ก.พ. 61

โรงพยาบาลวัฒโนสถเชิญชวนตรวจมะเร็งปอดเนื่องในวันงดสูบบุหรี่โลก (Package Lung Cancer Early Detection ) — โรงพยาบาลวัฒโนสถ ขอเชิญชวนผู้ที่สนใจตรวจสุขภาพ "ป้อ... พ.ค. 60

Registration & Abstract Submission Open for IASLC's 2016 World Conference on Lung Cancer in Vienna

Largest Worldwide Lung Cancer Research Organization Invites Global Collaborators to Attend Registration and abstract submission is now open for the International Association for the Study of Lung Cancer... มี.ค. 59

Global Strategic Partners Merck and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer

Not intended for UK-based media First of several registration trials expected to start in 2015 for the alliance between Merck and Pfizer Initiation and first... เม.ย. 58

Merck Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer